CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 4 Planned sale Chief R&D Officer sold 3,867 shares at $35.67 ($137,936)
- 144 Insider Sale of Securities
- 4 Grant or award Chief R&D Officer acquired 6,250 shares (grant or award)
- 4 Grant or award President & CEO acquired 21,667 shares (grant or award)
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale Chief R&D Officer sold 1,157 shares at $54.28 ($62,802)
- 4 Open-market sale Chief Legal Officer sold 630 shares at $54.28 ($34,196)
- 4 Open-market sale President & CEO sold 2,207 shares at $54.28 ($119,796)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 4 of 100 · 1,982 filings